TomEnterprise AB - 23 Jul 2025 SCHEDULE 13G/A Report for DiaMedica Therapeutics Inc. Common Shares, no par value (DMAC)

Filing Manager
TomEnterprise AB
Reporting Manager
TomEnterprise AB
Security
DiaMedica Therapeutics Inc. Common Shares, no par value
Symbol
DMAC
Shares outstanding
51,496,173 shares
Disclosed Ownership
8,383,577 shares
Ownership
16.3%
Form type
SCHEDULE 13G/A
Filing time
30 Jul 2025, 17:31:32 UTC
Date of event
23 Jul 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TomEnterprise AB 16.3% 8,383,577 0 8,383,577 /s/ Per Colleen Chief Executive Officer
TomEnterprise Private AB 16.3% 8,383,577 0 8,383,577 /s/ Per Colleen Chief Executive Officer
Thomas von Koch 16.3% 8,383,577 0 8,383,577 /s/ Thomas von Koch Thomas von Koch